Kindai University Hospital
Kindai University Hospital
Sakai, Osaka, Japan7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-08 | NCT07566052 | |
| A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma. | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT07734116 | |
| A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 3 | 2026-09-22 | NCT07409272 | |
| A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, gastric adenocarcinoma, neoplasm, pancreatic adenocarcinoma | Recruiting | Phase 1 | 2026-09-11 | NCT05365581 | |
| A Study of ONO-7429 in Participants With Unresectable Advanced or Recurrent Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-08-26 | NCT07787208 | |
| Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure | Acute Heart Failure | Recruiting | Phase 4 | 2026-08-10 | NCT07397650 | |
| A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors | non-small cell lung carcinoma | Active, not recruiting | Phase 1 | 2026-08-05 | NCT06816108 |